{
    "eid": "2-s2.0-84927695900",
    "title": "Update on Biomarkers of Hepatocellular Carcinoma",
    "cover-date": "2015-01-01",
    "subject-areas": [
        {
            "$": "Gastroenterology",
            "@code": "2715"
        },
        {
            "$": "Hepatology",
            "@code": "2721"
        }
    ],
    "keywords": [
        "Early detection",
        "Liver cancer",
        "Prognosis",
        "Prognostic factor",
        "Tumor",
        "\u03b1-Fetoprotein"
    ],
    "authors": [
        "Roongruedee Chaiteerakij"
    ],
    "citedby-count": 110,
    "ref-count": 53,
    "ref-list": [
        "Systems cancer medicine: Towards realization of predictive, preventive, personalized and participatory (P4) medicine",
        "A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures",
        "Phases of biomarker development for early detection of cancer",
        "Improving screening for hepatocellular carcinoma by incorporating data on levels of \u03b1-fetoprotein, over time",
        "Gut",
        "Identification of osteopontin as a novel marker for early hepatocellular carcinoma",
        "Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C",
        "Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles",
        "Randomized controlled trial of screening for hepatocellular carcinoma",
        "Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study",
        "Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis",
        "Combined \u03b1 fetoprotein testing and ultrasonography as a screening test for primary liver cancer",
        "\u03b1-Fetoprotein, Des-\u03b3 Carboxyprothrombin, and Lectin-Bound \u03b1-Fetoprotein in Early Hepatocellular Carcinoma",
        "Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients",
        "Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size",
        "Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP",
        "A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: A meta-analysis",
        "Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: Can we predict earlier?",
        "Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis",
        "Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma",
        "Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis",
        "New utility of an old marker: Serial \u03b1-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy",
        "Model to estimate survival in ambulatory patients with hepatocellular carcinoma",
        "Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma",
        "Early increase in \u03b1-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib",
        "Novel des-\u03b3-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma",
        "Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma",
        "Enhanced detection of hepatocellular carcinoma",
        "Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma",
        "Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers",
        "GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers",
        "Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma",
        "Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma",
        "Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers",
        "PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis",
        "GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma",
        "Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma",
        "Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases",
        "Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma",
        "Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma",
        "Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry",
        "Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry",
        "A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection",
        "Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets",
        "Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling",
        "FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma",
        "Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma",
        "Tivantinib for second-line treatment of advanced hepatocellular carcinoma: A randomised, placebo-controlled phase 2 study",
        "Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival",
        "Identification of metastasis-related microRNAs in hepatocellular carcinoma",
        "MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan criteria",
        "Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma",
        "Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic Cancer Center",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "National Cancer Institute",
        "National Cancer Institute"
    ]
}